LAURA BEDNAR: Open Payments
NPI 1043044811 · STURGIS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 55 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $321 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $154 |
| Axsome Therapeutics, Inc. | 6 | $150 |
| ABBVIE INC. | 7 | $120 |
| PFIZER INC. | 6 | $114 |
| Astellas Pharma US Inc | 4 | $92 |
| Novo Nordisk Inc | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $60 |
| Corcept Therapeutics | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
Products named: Auvelity, NURTEC ODT, Veozah, AIRSUPRA, VRAYLAR, CAPLYTA, Kerendia, FARXIGA.
Industry payments across MI — which companies pay providers there.
